Skip to Content
Investing Specialists

Weekly Wrap: Stocks, Funds, and Lessons From the Second Quarter

We recap the week on Morningstar.com and note the most popular stocks, funds, and exchange-traded funds.

Mentioned: , , , , , , , , ,
Editor's note: Read the latest on how the coronavirus is rattling the markets and what investors can do to navigate it.

The first half of 2021 is officially in the books. The stock market notched double-digit gains, earnings growth was healthy, and inflation heated up. Thanks to rising coronavirus vaccination rates here in the United States, we seem to be on track for a return to something resembling normalcy. In fact, I'm writing this week's edition of Smart Investor from my desk at Morningstar's Chicago office--my first time sitting in this chair since March 2020.

What can we expect in the year's second half? I'm no crystal-ball gazer, but based on the commentary of Morningstar's analysts and strategists featured in our quarter-end coverage, here are a few of my thoughts for what the next six months may bring:

  • The economic recovery will continue to move quickly because of soaring consumer demand. We're going to restaurants. We're flying. We're going to see movies. Our spending may shift away from goods and more toward services as the country continues to reopen, but we will nevertheless spend, spend, spend for the foreseeable future--and that will drive strong economic growth.
  • Inflation will continue to rise, at least in the short term, given robust consumer activity and supply-chain challenges. Morningstar expects full-year inflation to clock in near 3% for 2021--the highest level since 2008.
  • The oil markets will remain tight this year as global demand continues to outpace supply. Filling our tanks probably won't be getting cheaper anytime soon.

What does this outlook mean for our investments? Morningstar director of personal finance Christine Benz suggests that retirees make sure they have some inflation protection in their portfolios. She also recommends that investors nearing retirement still maintain a high-quality, short- to intermediate-term bond buffer, despite the constrained returns that the asset class offers today. And although wide-moat stocks have outperformed the market this year, Morningstar U.S. market strategist Dave Sekera thinks now is a good time to trade up to high-quality companies.

For more insights from Morningstar's specialists about the quarter in funds, stocks, and the market, check out our special report, "Morningstar's Take on the Second Quarter."

--Susan Dziubinski

Editor's Picks

Morningstar's Take on the Second Quarter
Our analysis of the second quarter in stocks and funds.

3 Investment Lessons From the First Half of 2021
For the most part, the markets behaved in line with expectations.

Digging Into Vanguard Dividend Growth
The fund stands out for its focus on companies with a strong competitive advantage that can sustain and grow their dividends over time.

An Executor's Guide to Inherited Retirement Benefits: RMDs
Here's a rundown of an estate's options and obligations related to required minimum distributions.

Tesla Charges Ahead
We boosted our valuation on an improved profit outlook, but the EV maker still isn’t a buy.

Why Bonds Still Matter
Low yields and the potential for rising inflation notwithstanding, bonds are still valuable within a diversified portfolio.

Portfolio Planning and Personal Finance With Christine Benz

Don't Be Dogmatic About Retirement-Portfolio Withdrawals
In high- (or low-) tax years, retirees may have reason to flout the rules of thumb on withdrawal sequencing.

Mutual Funds and Exchange-Traded Funds

The Second Quarter in Bond Funds
A respite from rising rates.

The Second Quarter in International Stock Funds
Growth led the markets, while value and Asia took a breather.

The Year in ETFs so Far
Ben Johnson gives a midyear report on the exchange-traded fund landscape.

Stocks

Q2 Top Stock Performers on Morningstar's Coverage List
Energy and tech stocks lead as the U.S. market rally continued.

Market Outlook: Stocks Looks Fairly Valued
It's a good time to trade up to wide-moat companies.

Economic Outlook: Recovery Moving Quickly Thanks to Soaring Consumer Demand
We've increased our GDP forecast.

Should These 11 Travel Stocks Be on Your Radar?
These companies stand to benefit from pent-up demand--but they aren’t all undervalued today.

Drugmakers, Biotech Pressured by Policy Risk, but We Don't Expect Big Regulatory Changes
We also expect a return to more elective procedures.

Should I Invest in Airbnb?
The market’s optimistic valuation for Airbnb is tough to accommodate.

The State of Streaming Companies
We maintain that Netflix is overvalued but see potential in ViacomCBS.

Rekenthaler Report

The Best Investment Politics Is Strong Performance
The safest way to deliver that performance is through indexing.

Advisor Insights

Building a Virtual Practice
There are many benefits to having a virtual advisory business, here's how to make it work.

How Different Generations Define Retirement
Individuals touched on the aging process, fun and freedom, and a little stress.

The Long View Podcast

Leif Dahleen: Finding Financial Independence
The Physician on FIRE blogger discusses the financial and lifestyle choices that go into retiring early, passive sources of income, and why and how he and his family give back.

Commentary

Speculating and Investing Are Not One and the Same
Author and Wall Street Journal columnist Jason Zweig talks trading trends and the future of the fiduciary standard.

Most Requested Stock Quotes

Apple
Alibaba Group
Amazon.com
Microsoft
Tesla

Most Requested Fund Quotes

Vanguard Dividend Growth
Fidelity 500 Index
Vanguard 500 Index
Dodge & Cox
Vanguard Total Stock Market Index

Most Requested ETF Quotes

Invesco QQQ Trust
Vanguard S&P 500 ETF
Vanguard Total Stock Market ETF
SPDR S&P 500 ETF Trust
Vanguard High Dividend Yield

Morningstar.com does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.